# High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix

> **NCT00193830** · PHASE3 · COMPLETED · sponsor: **Tata Memorial Hospital** · enrollment: 750 (—)

## Conditions studied

- Cancer of Cervix
- Cervical Cancer
- Cancer of the Cervix
- Cervix Cancer

## Interventions

- **PROCEDURE:** HIgh Dose Rate Vs Low DOse Rate Brachytherapy

## Key facts

- **NCT ID:** NCT00193830
- **Lead sponsor:** Tata Memorial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-05
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 750 (—)
- **Last updated:** 2015-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00193830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00193830, "High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00193830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
